retatrutide phase 2 trial new england journal of medicine for Obesity 💉 A triple-action once-weekly injection

doi:10.1001/jama.2021.1831.Opens in a new tab KFF

Tesamorelin also supports muscle preservation through GH and IGF-1 elevation, potentially counteracting the lean mass loss associated with aggressive weight loss peptide protocols

The company plans to test orforglipron for maintenance of weight loss in people who participated in another Lilly trial, comparing its drug Zepbound with Novo Nordisks Wegovy

This reduces the pleasure associated with high-calorie food consumption, helping to decrease overeating

Its important to note that medication effectiveness can vary between individuals, and the choice of weight loss medication should be made in consultation with a healthcare professional

The new flavors are designed to be mixed, sipped and savored, ideal for high-fiber mocktails that naturally activate GLP-1, the satiety hormone that helps control appetite and cravings, the company says